跳至主要内容
临床试验/KCT0008336
KCT0008336尚未招募Unknown

The efficacy and safety of clonal mesenchymal stem cell therapy for Hutchinson-Gilford Progeria syndrome

Inha University Hospital0 个研究点目标入组 1 人开始时间: 待定最近更新:
适应症

试验速览

阶段
Unknown
状态
尚未招募
入组人数
1

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
o Limit 至 o Limit(—)
性别
All

入选标准

  • 1. Genetically confirmed Hutchinson-Gilford progeria syndrome (progeria in childhood)
  • 2. Typical clinical symptoms of progeria identified by medical staff in this clinical study
  • 3. Aspartate aminotransferase (AST) and alanine aminotransfers (ALT) at the time of enrollment/screening < 5× upper limit of normal
  • 4. Research subjects and legal representatives who must be able to visit the center according to this research plan and who are willing to participate voluntarily

排除标准

  • Research subjects who fall under any of the following are excluded from the study.
  • 1. Severe renal impairment (GFR < 30ml/min/1.73m2)
  • 2. Other clinical study medications received 90 days prior to the first treatment visit
  • 3.Persons with serious adverse reactions during stem cell treatmen
  • 4. In the case of a medical condition that prevents safe participation in the study according to the opinion of the research director

研究者

相似试验